198 related articles for article (PubMed ID: 29046940)
1. Gastric cancer: immunohistochemical classification of molecular subtypes and their association with clinicopathological characteristics.
Birkman EM; Mansuri N; Kurki S; Ålgars A; Lintunen M; Ristamäki R; Sundström J; Carpén O
Virchows Arch; 2018 Mar; 472(3):369-382. PubMed ID: 29046940
[TBL] [Abstract][Full Text] [Related]
2. High-throughput Protein and mRNA Expression-based Classification of Gastric Cancers Can Identify Clinically Distinct Subtypes, Concordant With Recent Molecular Classifications.
Ahn S; Lee SJ; Kim Y; Kim A; Shin N; Choi KU; Lee CH; Huh GY; Kim KM; Setia N; Lauwers GY; Park DY
Am J Surg Pathol; 2017 Jan; 41(1):106-115. PubMed ID: 27819872
[TBL] [Abstract][Full Text] [Related]
3. EGFR gene amplification is relatively common and associates with outcome in intestinal adenocarcinoma of the stomach, gastro-oesophageal junction and distal oesophagus.
Birkman EM; Ålgars A; Lintunen M; Ristamäki R; Sundström J; Carpén O
BMC Cancer; 2016 Jul; 16():406. PubMed ID: 27387915
[TBL] [Abstract][Full Text] [Related]
4. Integrated gene copy number and expression microarray analysis of gastric cancer highlights potential target genes.
Myllykangas S; Junnila S; Kokkola A; Autio R; Scheinin I; Kiviluoto T; Karjalainen-Lindsberg ML; Hollmén J; Knuutila S; Puolakkainen P; Monni O
Int J Cancer; 2008 Aug; 123(4):817-25. PubMed ID: 18506690
[TBL] [Abstract][Full Text] [Related]
5. Gastric Cancer With Primitive Enterocyte Phenotype: An Aggressive Subgroup of Intestinal-type Adenocarcinoma.
Yamazawa S; Ushiku T; Shinozaki-Ushiku A; Hayashi A; Iwasaki A; Abe H; Tagashira A; Yamashita H; Seto Y; Aburatani H; Fukayama M
Am J Surg Pathol; 2017 Jul; 41(7):989-997. PubMed ID: 28505005
[TBL] [Abstract][Full Text] [Related]
6. A case of gastric cancer with heterogeneous components of EB virus (+)/TP53 (+) and EB virus (-)/TP53 (-).
Matsuda I; Kan K; Doi S; Motoki Y; Onodera M; Hirota S
Int J Clin Exp Pathol; 2015; 8(9):11766-71. PubMed ID: 26617924
[TBL] [Abstract][Full Text] [Related]
7. Gastric hepatoid adenocarcinomas are a genetically heterogenous group; most tumors show chromosomal instability, but MSI tumors do exist.
Tsuruta S; Ohishi Y; Fujiwara M; Ihara E; Ogawa Y; Oki E; Nakamura M; Oda Y
Hum Pathol; 2019 Jun; 88():27-38. PubMed ID: 30946937
[TBL] [Abstract][Full Text] [Related]
8. Association of tumor-infiltrating T lymphocytes with intestinal-type gastric cancer molecular subtypes and outcome.
Mansuri N; Birkman EM; Heuser VD; Lintunen M; Ålgars A; Sundström J; Ristamäki R; Lehtinen L; Carpén O
Virchows Arch; 2021 Apr; 478(4):707-717. PubMed ID: 32954467
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of spasmolytic polypeptide-expressing metaplasia and intestinal metaplasia in Epstein-Barr virus-associated and Epstein-Barr virus-negative gastric cancer.
Zhang Y; Chen JN; Dong M; Zhang ZG; Zhang YW; Wu JY; Du H; Li HG; Huang Y; Shao CK
Hum Pathol; 2017 May; 63():128-138. PubMed ID: 28300576
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemistry as a surrogate for molecular subtyping of gastric adenocarcinoma.
Gonzalez RS; Messing S; Tu X; McMahon LA; Whitney-Miller CL
Hum Pathol; 2016 Oct; 56():16-21. PubMed ID: 27342907
[TBL] [Abstract][Full Text] [Related]
11. Lymphocyte-rich gastric cancer: associations with Epstein-Barr virus, microsatellite instability, histology, and survival.
Grogg KL; Lohse CM; Pankratz VS; Halling KC; Smyrk TC
Mod Pathol; 2003 Jul; 16(7):641-51. PubMed ID: 12861059
[TBL] [Abstract][Full Text] [Related]
12. Down regulation of gastric and intestinal phenotypic expression in Epstein-Barr virus-associated stomach cancers.
Hirano N; Tsukamoto T; Mizoshita T; Koriyama C; Akiba S; Campos F; Carrasquilla G; Carrascal E; Cao X; Toyoda T; Ban H; Miki K; Tatematsu M
Histol Histopathol; 2007 Jun; 22(6):641-9. PubMed ID: 17357094
[TBL] [Abstract][Full Text] [Related]
13. HER2 positivity in gastric and esophageal adenocarcinoma: clinicopathological analysis and comparison.
Koopman T; Smits MM; Louwen M; Hage M; Boot H; Imholz AL
J Cancer Res Clin Oncol; 2015 Aug; 141(8):1343-51. PubMed ID: 25544671
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical Human Epidermal Growth Factor Receptor 2 (HER2) Expression Pattern in Gastric Adenocarcinomas in a Nigerian Tertiary Hospital.
Mashor MI; Ezenkwa US; Ogun GO; Ajani MA; Ogunbiyi JO
West Afr J Med; 2024 Mar; 41(3):311-316. PubMed ID: 38788150
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological significance of cathepsin D expression in gastric adenocarcinoma.
Ikeguchi M; Fukuda K; Oka S; Yamaguchi K; Hisamitsu K; Tsujitani S; Sakatani T; Ueda T; Kaibara N
Oncology; 2001; 61(1):71-8. PubMed ID: 11474252
[TBL] [Abstract][Full Text] [Related]
16. Comparing intestinal versus diffuse gastric cancer using a PEFF-oriented proteomic pipeline.
Wippel HH; Santos MDM; Clasen MA; Kurt LU; Nogueira FCS; Carvalho CE; McCormick TM; Neto GPB; Alves LR; da Gloria da Costa Carvalho M; Carvalho PC; Fischer JSDG
J Proteomics; 2018 Jan; 171():63-72. PubMed ID: 29032071
[TBL] [Abstract][Full Text] [Related]
17. Receptor tyrosine kinase amplified gastric cancer: Clinicopathologic characteristics and proposed screening algorithm.
Park CK; Park JS; Kim HS; Rha SY; Hyung WJ; Cheong JH; Noh SH; Lee SK; Lee YC; Huh YM; Kim H
Oncotarget; 2016 Nov; 7(44):72099-72112. PubMed ID: 27765925
[TBL] [Abstract][Full Text] [Related]
18. Gastric and intestinal phenotypic cell marker expressions in gastric differentiated-type carcinomas: association with E-cadherin expression and chromosomal changes.
Morohara K; Tajima Y; Nakao K; Nishino N; Aoki S; Kato M; Sakamoto M; Yamazaki K; Kaetsu T; Suzuki S; Tsunoda A; Tachikawa T; Kusano M
J Cancer Res Clin Oncol; 2006 Jun; 132(6):363-75. PubMed ID: 16447040
[TBL] [Abstract][Full Text] [Related]
19. Fetal-type gastrointestinal adenocarcinoma: a morphologically distinct entity with unfavourable prognosis.
Arora K; Bal M; Shih A; Moy A; Zukerberg L; Brown I; Liu X; Kelly P; Oliva E; Mullen J; Ahn S; Kim KM; Deshpande V
J Clin Pathol; 2018 Mar; 71(3):221-227. PubMed ID: 28814568
[TBL] [Abstract][Full Text] [Related]
20. Surgical treatment results of intestinal and diffuse type gastric cancer. Implications for a differentiated therapeutic approach?
Stiekema J; Cats A; Kuijpers A; van Coevorden F; Boot H; Jansen EP; Verheij M; Balague Ponz O; Hauptmann M; van Sandick JW
Eur J Surg Oncol; 2013 Jul; 39(7):686-93. PubMed ID: 23498364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]